Bruce L.A. Carter, 50 years old, was elected a director of this biotechnology concern, increasing the board's size to six members.
Dr. Carter is president of ZymoGenetics Inc., a Seattle biotech company, and chief scientific officer of the health-care group of Denmark-based Novo Nordisk AS.
